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Abstract Hepatitis E virus (HEV) is a causative agent of
infectious hepatitis in animals and humans both in devel-
oping and developed countries. Here, we collected 500
sheep sera and 75 raw sheep liver samples from a
slaughterhouse in the southern part of the Xinjiang region,
China, along with 26 sera of butchers from the same
slaughterhouse. All serum samples were tested for anti-
HEV antibody by enzyme-linked immunosorbent assay.
Both serum and liver samples were evaluated for the
presence of HEV RNA by nested polymerase chain reac-
tion targeting partial nucleotide sequences of open reading
frame 2 (ORF2). The results indicate that sheep sero-
prevalence was 35.20 % (176/500) and that four of the 75
(5.3 %) sheep livers showed detectable amounts of HEV
RNA. The seroprevalence of the butchers was 57.7 % (15/
26). The four amplicons shared 97.8–100 % nucleotide
sequence identity and had pairwise sequence identities of
81.6–85.3 %, 84.2–85.3 %, 82.1–85.3 % and 84.7–97.9 %
with the corresponding regions of genotypes 1, 2, 3 and 4
of HEV, respectively. A phylogenetic tree was constructed
based on alignments of an amplified 186-bp ORF2 se-
quence and corresponding reference strains. The analysis
showed that the four sheep strains detected in our study
formed a lineage within a genotype 4 cluster that contains
hb-3, bjsw1, T1, swCH189 and swCH25, all of which be-
long to genotype 4, subtype 4d. The results indicated a high
level of seroconversion in sheep and suggested that sheep
liver may be a source of foodborne HEV infection in
humans.
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Introduction
Infections with hepatitis E virus (HEV) are an important
public health concern in many developing countries in Asia
and Africa where sanitation conditions are suboptimal [1–
3]. Sporadic cases of HEV infection have also been re-
ported in many industrialised countries where transmission
of the virus is mainly zoonotic [4–7]. HEV infections are
typically self-limiting and asymptomatic. Nevertheless,
symptomatic infections can occur and are often mistaken
for drug-induced liver injury [8, 9]. In pregnant women
living in countries where HEV is highly endemic, HEV
infections have a 20 % mortality rate. Moreover, up to
70 % of people with underlying chronic liver disease may
develop an often fatal, fulminant hepatitis [4, 10–13].
HEV is the only species of the genus Hepevirus, which
belongs to the Hepeviridae family [14]. It is a non-en-
veloped, single-stranded, positive-strand RNA virus with a
7.2-kb genome that consists of three discontinuous open
reading frames (ORFs; ORF1, ORF2 and ORF3) and
flanking untranslated regions. ORF1 encodes non-structural
proteins that are involved in viral replication and viral
protein processing. Their putative functional domains may
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have methyltransferase, papain-like cysteine protease, he-
licase and RNA-dependent RNA polymerase activities.
Other domains are homologous to domains found in other
positive-strand RNA viruses, such as Y, X or macro
domains and polyproline regions. ORF2 occupies the 30-
terminal part of the genome and encodes a glycoprotein of
the viral capsid. ORF3 encodes a cytoskeleton-associated
phosphoprotein that is required for virion release from cells
and is associated with numerous cellular pathways [15–24].
Although all HEV strains may belong to a single serotype
[25, 26], phylogenetic analysis of HEV sequences has led to
the recognition of the existence of at least four major geno-
types [27–29]. Genotype 1 and 2 HEVs are restricted to
humans and are often associated with large outbreaks and
epidemics in developing countries in Asia and Africa.
Genotype 3 and 4 HEVs have been isolated from humans and
from several animal species, including pigs, wild boars, deer
and mongooses. Genotype 3 is distributed globally and found
equally in industrialised and developing countries, whereas
genotype 4 is mainly found in Asian and European countries
[14, 30–42]. Recently, new HEV variants have been identi-
fied in rats, wild boars, ferrets, bats, chickens and cutthroat
trout [43–50], and a cluster of HEV strains has been identi-
fied in farm rabbits in China, the USA and France [51–55].
The rabbit strains of HEV from these countries belong to
genotype 3 [29, 37]. Many questions concerning HEV in-
fections, however, remain open. For example, it is unclear
whether all HEV genotypes can infect the above-mentioned
species and whether newly identified HEV variants can in-
fect humans or only animals.
The consumption of contaminated drinking water is
generally considered the primary source of HEV transmis-
sion to humans. With the discovery of foodborne transmis-
sion after ingesting raw or undercooked meat or inner organs,
however, this viewpoint is gradually changing [7, 56–59].
Some recent studies indicate that HEV may spread to hu-
mans through the food chain from animal reservoirs, such as
swine, deer, or wild boar [60, 61]. Hence, studies on HEV
circulation in different species providing integrated farm-to-
table risk assessments are urgently needed.
In China, Xinjiang is one of the main areas affected by
HEV infection, and two large-scale outbreaks have oc-
curred in its southern region [62]. Sheep are raised abun-
dantly in these areas, and mutton and sheep viscera are
commonly eaten by local inhabitants, in particular by
Uighurs. Wang and Ma [63] confirmed the existence of
genotype 4 HEV in sheep faecal samples in this region, and
Wu et al. [64] further reported geographical, breed and age-
related differences in HEV prevalence. Studies on whether
HEV can also be disseminated via sheep liver, however,
are limited. The aim of the present study was to acquire
serological evidence for HEV infections and to assess the
potential for HEV infections to be foodborne in this region.
Materials and methods
Serum and liver specimens
A total of 575 sheep samples from clinically healthy sheep
were collected in January and February 2014 at a slaugh-
terhouse in the southern part of Xinjiang region, China
(procedures were approved by the Xinjiang Uighur Au-
tonomous Region Animal Care and Use Committee). They
included 500 sera (150 of them from sheep\1 year of age,
and 350 from sheep of C2 years of age) and samples from
livers of 75 additional sheep of various ages for which no
sera were available. Sera from 26 Uighur butchers working
in the same slaughterhouse were also collected, and all of
them had worked continuously at the slaughterhouse for
more than 3 years (procedures were approved by the
Xinjiang Uighur Autonomous Region Centers for Disease
Control and Prevention). The sheep came from three dif-
ferent farms from the surrounding area (Fig. 1), i.e., an area
where two large-scale outbreaks involving 120,000 in-
fected people had occurred between September 1986 and
April 1988. Hetian county is a representative epidemic
focus where two human HEV strains were isolated from
Uighurs during this time, and in which farms A and B were
located [62]. Animal quarantine archives indicated that
sheep raised in high density at each farm were gathered
from farmers scattered through the region. At the slaugh-
terhouse, the sheep from the three different farms were
housed separately for 2 days in sheepfolds before slaugh-
ter. Samples were stored at -80 C until processing.
Detection of anti-HEV antibody
All serum samples collected from sheep and butchers were
tested for anti-HEV antibody using a direct sandwich en-
zyme-linked immunosorbent assay (ELISA) kit (Cat. No:
HEV-0496, Beijing Wantai Biopharmaceutical, Inc.), ac-
cording to the manufacturer’s instructions.
RNA extraction and nested reverse transcription
polymerase chain reaction (RT-nPCR)
Approximately, 10–20 mg of each liver sample was ho-
mogenised on ice with phosphate buffered saline (PBS;
0.01 M, pH 7.2–7.4) using an automatic homogeniser and a
sterile micropestle. The tissue suspensions were cleared by
centrifugation at 12,000 rpm for 15 min at 4 C. Duplicate
supernatants (150 ll) were prepared and stored at -80 C.
Total RNA was extracted from aliquots of the cleared liver
material (or 150 ll serum) with TRIZOL (Invitrogen) ac-
cording to the manufacturer’s protocol and eluted in 20 ll
of RNase-free water.
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Extracted viral RNA was used immediately for reverse
transcription and cDNA synthesis with a PrimeScriptTM II
First-strand cDNA Synthesis Kit (Cat. No: 6210A, Takara),
followed by nPCR with primers targeting HEV ORF2 re-
gions as described previously. The results of the nPCR
strategy for HEV genotyping correlated well with those of
phylogenetic analyses conducted on the basis of the com-
plete HEV genome [65]. In our study, first round amplifi-
cation was achieved with the external forward primers P1
(50-AATGGWGTTGGYGAGGTC-30) and the reverse pri-
mer P2 (50-WGARAGCCAAAGCACATC-30). For nPCR,
the internal forward and reverse primers were P3 (50-
TGTTTAATCTTGCTGATACG-30) and P4 (50-TGYTGG
TTRTCRTAATCCTG-30), respectively. The two rounds of
PCR amplification were both carried out in 25-ll reaction
volumes containing 2.5 ll of 10 9 PCR buffer, 1 ll of
10 mM dNTPs, 0.5 ll (5 U) Taq DNA polymerase (Roche
Molecular Systems), 1 ll (10 lM) each of sense (external or
internal) and anti-sense primers, 2 ll template and 17 ll
sterile water for 35 cycles of 94 C for 30 s (additional 5 min
for the first cycle), 53 C for 30 s and 72 C for 40 s (addi-
tional 10 min for the last cycle). Negative (diethyl pyrocar-
bonate water) and positive (positive swine liver) control
samples were included during RNA extraction and first and
second PCRs. The reaction system and conditions used in our
study were capable of detecting 2.5 ng HEV RNA in liver,
which was determined using serial mixtures by adding ten-
fold dilutions of swine HEV RNA into the swine liver sus-
pensions with the same concentration. To avoid cross-
contamination, each phase of the procedure was carried out
using various precautions, including the use of separate
rooms, specialised equipment, pipettes and disposable
gloves. The final PCR product was analysed by 1.2 % (w/v)
agarose gel electrophoresis, and the size of the nPCR product
was 226 bp, including 40-bp primer regions.
Sequencing and phylogenetic analysis
Nested PCR products were excised from agarose gels and
purified using HiPure Gel Pure DNA Kits (Cat. No: D2110-
03, Magen). Purified RT-PCR products were cloned into
the pGEM-T Easy Vector (Cat. No: A1380, Promega) and
sequenced with an M13 primer. After trimming off the
40-nt primer regions, sequences were assembled and
aligned with other swine and human HEV sequences pre-
sent in the NCBI GenBank. Sequence alignments were
generated by CLUSTAL-W (version 2.0). Genetic dis-
tances between pairs of viral strains were calculated with
MEGA software (version 5.0) using the Kimura two-pa-
rameter method. Percent identity was calculated with
Fig. 1 Geographical
distribution of the three
different farms in Xinjiang. On
the map of China, different
provinces are marked with
different colours. The Xinjiang
Uighur Autonomous Region is
marked in light blue. The three
farms were distributed in the
southern part of Xinjiang, which
is demarcated by a black line.
Open star indicates Hetian
region. Open circle indicates
Hetian county of Hetian region
where farms A and B were
located and which corresponds
to the area where the two large-
scale outbreaks during 1986 and
1988 occurred. Open diagonal
indicates Aksu region where
farm C was located (Color
figure online)
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Lasergene (version 5.03; DNAstar). Phylogenetic trees
were constructed by the neighbour-joining method, and
1000 resamplings of the data were used to calculate per-
centages of the obtained branches. Reference strains for
each of the four genotypes, selected to represent the geo-
graphical source and host variation, were used for phylo-
genetic analysis.
Statistical analysis
To identify a possible correlation between anti-HEV
seroprevalence and the age of animals, sheep were divided
in two groups (young animals: \1 year old, and adult
animals: C2 years old). All statistical analyses were per-
formed using SPSS software (version 16.0).
Results
Seroprevalence of anti-HEV antibody and HEV
RNA
All serum samples were tested for anti-HEV antibody and
HEV RNA. The sheep seroprevalence of anti-HEV anti-
body was 35.2 % (176/500). There were statistically sig-
nificant differences between the two age groups, with
45.7 % (160/350) positivity among the adult cohort, and
10.7 % (16/150) positivity among young animals
(p\ 0.01). The seroprevalence of butchers was 57.7 %
(15/26). None of the serum samples were positive for HEV
RNA.
Detection of HEV RNA in liver samples
To determine whether sheep liver was infected with HEV,
75 raw sheep livers were tested for the presence of HEV
RNA by RT-nPCR. At least five samples were harvested
and analysed from each liver. Four of the 75 livers gave at
least one sample with detectable amounts of HEV RNA
(Table 1).
Phylogenetic analysis of HEV isolated from sheep
ORF2 fragments (186 bp) amplified from the sheep HEV
genome were compared with the corresponding sequences
of other human and swine HEV strains deposited in Gen-
Bank. Sequence analysis indicated that these four sheep
HEV strains designated as XJNJSLhev25, XJNJSLhev27,
XJNJSLhev28 and XJNJSLhev30 (GenBank accession
numbers KP294330- KP294333) shared 97.8–100 % nu-
cleotide homology with each other and had identities of
81.6–85.3 %, 84.2–85.3 %, 82.1–85.3 % and 84.7–97.9 %
with the corresponding regions of reference HEV geno-
types 1, 2, 3 and 4, respectively (Table 2). A high degree of
identity was observed between the strains found in the
current study and those described in a previous report, in-
cluding hb-3 (GU361892.1), bjsw1 (GU206559.1), T1
(AJ272108.1), swCH189 (FJ610232.1) and swCH25
(AY594199.1). Further phylogenetic analysis based on
alignment of partial ORF2 sequences revealed that the four
strains in the current study formed a single lineage and
were on the same branch as hb-3, bjsw1, T1, swCH189 and
swCH25, all of which belong to genotype 4, subtype 4d
[66] (Fig. 2). This finding suggested a common origin for
the currently circulating HEV strains in this region.
Discussion
HEV is a cause for public health concern in many devel-
oping countries where sanitation conditions are poor and
waterborne epidemics are frequent. Both epidemic and
sporadic forms of HEV infections exist in developing and
under-developed countries. Nevertheless, accumulating
evidence indicates that HEV-associated hepatitis can also
occur in individuals living in industrialised countries and
that zoonotic sources may be responsible for such cases [4–
6, 21, 61]. Swine are believed to be the principal reservoir
of HEV, but other animals, including cattle, dogs and ro-
dents, have also been reported to be highly seropositive for
anti-HEV IgG [67]. Given the high infection rates and
Table 1 Number of livers tested for HEV by RT-PCR
Source of liver
specimensa
No. of livers No. of positive
specimens (%)b
Name of HEV strains Accession numbers
A 30 1(3.3) XJNJSLhev25 KP294330




C 10 1(10) XJNJSLhev27 KP294331
Total 75 4(5.3) /
a Letters refer to three different farms where the sheep were bred
b Numbers in brackets represent the respective percentages
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expanded HEV host range, increasing attention has been
focused on the zoonotic nature of HEV and the close as-
sociation of particular animal species with humans. In fact,
numerous cases of human HEV sharing high genomic se-
quence identity with virus isolates from local animals have
recently been reported [7, 68, 69]. All of these findings
strongly support a zoonotic transmission, which also
explains the cause of autochthonous HEV infections in
developed countries. Furthermore, numerous examples of
human infections via consumption of contaminated raw
meat or other animal products have surfaced in recent
years. In Germany, autochthonous HEV infection was
found to be associated with the consumption of offal and
wild boar meat [70]. Similar events have occurred in Japan,
Table 2 Pairwise sequence
identities between the four
sheep liver HEV sequences and
corresponding sequences of
reference strains of the four
genotypes (%)
Sequencesa 1(13) 2(1) 3(12) 4(20) Sheep sequences
Sheep sequences 81.6–85.3 84.2–85.3 82.1–85.3 84.7–97.9 97.8–100.0
4(20) 80.5–88.4 83.7–86.8 78.9–86.8 86.3–100.0
3(12) 80.5–91.1 80.0–86.8 80.5–100.0
2(1) 83.7–87.9 100.0
1(13) 88.9–100.0
a Numbers out of parentheses represent genotypes of reference sequences. Numbers in parentheses rep-
resent number of reference sequences
Fig. 2 Phylogenetic tree based on a 186-bp nucleotide sequences of
HEV-ORF2. The tree was constructed by the neighbour-joining
method using 46 animal and human HEV reference strains. Strains
characterised in this study were indicated with symbol filled triangle.
The internal node numbers indicated the bootstrap values as a
percentage obtained from 1000 replications. The Arabic numbers and
the English letters outside of the dashed curves indicate the genotype
and subtype. The bar on the tree shows the scale of 0.05 % nucleotide
substitution per site. GenBank accession numbers, country and
species of origin are indicated for each isolate represented on the tree
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France and the USA [7, 68, 69]. These events alert us to the
necessity for constant surveillance of HEV transmission
routes in order to prevent foodborne epidemics.
In China, endemic hepatitis E can be traced back to
historical outbreaks in the 1980s in the Xinjiang Au-
tonomous Region, which has had the highest prevalence of
HEV infections worldwide. Several human and animal
viral genomes have been isolated, and phylogenetic ana-
lysis indicated that dominant HEV genotypes in this area
have converted from genotype 1 to genotype 4 [71, 72].
Interestingly, human HEV has been found mainly in
Uighurs, prompting a series of questions such as whether
this predilection is the result of a genetic predisposition or
of agricultural, social or food habits, whether there are
underlying co-morbidities, and what the principal infective
agents are. Here we focused particularly on the food habits
of the local inhabitants, of whom the majority are Uighurs.
For Uighurs, sheep meat is common in their diet. They
consume grilled meat, but also sheep liver and other inner
organs, and this was one of the major reasons why we
focused our study on sheep HEV. Our results indicated a
high HEV antibody prevalence in sheep herds in these
areas [64]. Interestingly, we found that by comparison with
our seroprevalence study performed previously in the same
area, the seroprevalence of anti-HEV antibody in sheep
was now even higher, indicating that sheep HEV is still
circulating in this region. Furthermore, two different age
groups of sheep showed significant differences in ser-
opositivity for anti-HEV antibody, with seroprevalence
increasing with age, possibly as a consequence of repeated
contact with the virus. In sheep less than 1 year of age, the
seroprevalence rate was 10.7 %, and in sheep 2 years or
older, it was 45.7 %. None of the 500 sheep serum samples
were positive for HEV RNA, and approximately 5.3 % (4
of 75) of raw sheep livers were HEV-positive. The fact that
the seroprevalence rate was higher than the percentage of
HEV-positive livers suggests that the period of viraemia is
relatively short. One might argue that the low frequency of
virus isolation from livers may be due to variations in virus
titers in different parts of this large organ. Indeed, samples
taken from 5 to 10 locations of the same liver showed
differences in virus positivity, but samples from many
other organs including muscle and several lymph nodes as
well as excretions such as bile, intestinal contents and
faeces were consistently negative. Hence, the liver still
gave us the best chance of finding evidence for the pres-
ence of virus.
Another interesting aspect of our study was the fact that
sheep and slaughterhouse workers showed antibodies to the
same antigen. We reached this conclusion because we used
the same ELISA kit capable of detecting antibodies to
highly purified ORF2 capsid protein of human HEV for
both sheep and human sera. This finding suggested that the
immune systems of both sheep and humans recognise an
overlapping set of immunogenic HEV proteins.
The phylogenetic tree (Fig. 2) revealed that the strains
identified in this study were most closely related to a human
HEV strain (T1, AJ272108.1) and four swine HEV strains
(hb-3, GU361892.1; bjsw1, GU206559.1; swCH189,
FJ610232.1; swCH25, AY594199.1). The strain swCH25 is
a swine HEV strain isolated in the area of Xinjiang, and the
human HEV strain and the remaining three swine HEV
strains were identified in different areas. However, all of
them belong to genotype 4, subtype 4d. Further epi-
demiological surveys should therefore be carried out to
confirm whether subtype 4d is the predominant strain cir-
culating in this region of China.
Conclusion
Our study showed for the first time that HEV RNA can be
detected in sheep liver samples. Hence, our results provide
strong evidence that sheep can be, and are, infected with
HEV and that sheep products, in particular liver and perhaps
other inner organs, can be a source of food born infections in
humans. Moreover, it appears that slaughterhouse workers
with extensive contact with sheep show a high rate of HEV
seroconversion. Our results underscore the need for further
studies to clarify epidemiological factors such as the distinct
pattern of sheep HEV distribution and the extent of cross-
species transmission.
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